Delivery Order SPE2DB24D1104-SPE2DB26FXTF8
Award Date 10/16/25
Potential Completion Date 11/6/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,115.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) on May 2, 2025, with an ultimate completion date of May 23, 2025. This non-competitive delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,231.20 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (10 units) on September 17, 2025. This competitive, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with fulfillment based at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Testopel 75 mg pellets valued at $10,289.00. This delivery order, issued on August 25, 2025, represents a firm fixed price contract with performance expected to conclude by September 16, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $4,115.58 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $8.2K. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,346.74 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (100-count units) with a completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- AmerisourceBergen Drug Corp received a delivery order award valued at $4,115.58 from the Defense Logistics Agency Medical Supply Chain on July 17, 2025, for the supply of Testopel 75 mg pellets (100-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive award executed under an existing contract vehicle. The work will be performed at the contractor's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 10S, a medical product, with a ceiling value of $9,877.44 and a performance period ending on July 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a $3,978.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,289,653 units of TESTOPEL 75 MG PELLETS 100S. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical products to various government agencies, including the military, under multiple indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100 units of Testopel 75 mg pellets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three weeks concluding in early September. As a major supplier of pharmaceuticals to the Department of Defense, this order for testosterone replacement therapy supports DLA's provision of medical...